
VistaGen Therapeutics (VTGN) Earnings Dates & Reports
VistaGen Therapeutics (VTGN) Most Recent Earnings
Report DateJun 17, 2025
Period EndingQ4 2025
Est. EPS-$0.49
Actual EPS-$0.44
EarningsBeat
VistaGen Therapeutics (VTGN) Earnings
View the latest VistaGen Therapeutics (VTGN) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in VistaGen Therapeutics (VTGN)
Order type
Buy in
Order amount
Est. shares
0 shares
VistaGen Therapeutics (VTGN) Earnings per Share (EPS) History
Signup for full accessBrowse free
VistaGen Therapeutics (VTGN) Latest Earnings
The value each VTGN share was expected to gain vs. the value each share gained.
VistaGen Therapeutics (VTGN) reported its most recent earnings on Jun 17, 2025 for Q4 2025, posting earnings per share (EPS) of -$0.44. This exceeded analysts' expectations of -$0.49 by 10.20%, marking a Beat.
For comparison, VistaGen Therapeutics reported EPS of -$0.25 in the same quarter last year.
The company is expected to announce its next earnings report on 08/12/2025, with analysts projecting an EPS of -$0.44.
VistaGen Therapeutics (VTGN) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q1 2026Aug 12, 2025 | -$0.44 | Next earnings call Aug. 12, 2025 | ||
Q4 2025Jun 17, 2025 | -$0.49 | -$0.44 | -10.20% | |
Q3 2025Feb 13, 2025 | -$0.52 | -$0.46 | -11.54% | |
Q2 2025Nov 7, 2024 | -$0.39 | -$0.42 | +7.69% | |
Q1 2025Aug 13, 2024 | -$0.40 | -$0.35 | -12.50% | |
VistaGen Therapeutics (VTGN) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the VistaGen Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Jun 17, 2025 | — | — | — |
Feb 13, 2025 | — | — | — |
Nov 7, 2024 | — | — | — |
Aug 13, 2024 | — | — | — |
VistaGen Therapeutics (VTGN) Earnings FAQs
VistaGen Therapeutics (VTGN) last reported earnings on Jun 17, 2025 for Q4 2025, posting an EPS of -$0.44, which Beat the estimate of -$0.49 by 10.20%.
For Q4 2025, VistaGen Therapeutics (VTGN) reported an EPS of -$0.44, exceeding analysts' estimate of -$0.49 by 10.20%.
For Q4 2025, VistaGen Therapeutics (VTGN) Beat expectations with an actual EPS of -$0.44 vs. an estimated EPS of -$0.49.
Following the last earnings report on Jun 17, 2025, VistaGen Therapeutics (VTGN)'s stock price moved — from — to —.
The next VistaGen Therapeutics (VTGN) earnings call is scheduled for Aug. 12, 2025, where executives will discuss financial results and outlook.